Drug recall D-0622-2024
Product
Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC# 49884-306-02.
Reason for recall
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.
Lots and codes
Lot 550147301, Exp. 08/31/2026
Recall details
- Recalling firm
- Endo Pharmaceuticals, Inc., Malvern, PA
- Quantity
- 8,139 cartons
- Distribution
- Nationwide in the USA and Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 10, 2024
- Terminated
- September 16, 2025
Related products
- Clonazepam – drug information
- NDC 49884-308 Clonazepam · Clonazepam .5 mg/1 · Par Health USA, LLC
- NDC 49884-306 Clonazepam · Clonazepam .125 mg/1 · Par Health USA, LLC
- NDC 49884-309 Clonazepam · Clonazepam 1 mg/1 · Par Health USA, LLC
- NDC 49884-310 Clonazepam · Clonazepam 2 mg/1 · Par Health USA, LLC
- NDC 49884-307 Clonazepam · Clonazepam .25 mg/1 · Par Health USA, LLC